BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19923488)

  • 1. Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.
    Jefferies JM; Smith AJ; Edwards GF; McMenamin J; Mitchell TJ; Clarke SC
    J Clin Microbiol; 2010 Jan; 48(1):87-96. PubMed ID: 19923488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
    Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
    Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
    J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.
    Carvalho Mda G; Pimenta FC; Gertz RE; Joshi HH; Trujillo AA; Keys LE; Findley J; Moura IS; Park IH; Hollingshead SK; Pilishvili T; Whitney CG; Nahm MH; Beall BW;
    J Clin Microbiol; 2009 Mar; 47(3):554-9. PubMed ID: 19116353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.
    Pichon B; Ladhani SN; Slack MP; Segonds-Pichon A; Andrews NJ; Waight PA; Miller E; George R
    J Clin Microbiol; 2013 Mar; 51(3):820-7. PubMed ID: 23269742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
    J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland.
    Clarke SC; Jefferies JMC; Smith AJ; McMenamin J; Mitchell TJ; Edwards GFS
    J Med Microbiol; 2006 Aug; 55(Pt 8):1079-1084. PubMed ID: 16849728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.
    Wagenvoort GH; Sanders EA; Vlaminckx BJ; de Melker HE; van der Ende A; Knol MJ
    Euro Surveill; 2017 Mar; 22(10):. PubMed ID: 28300529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW
    Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and microbiological characterization of serotype 6D pneumococcal infections in South Korea.
    Cheong HJ; Song JY; Choi MJ; Jeon JH; Kang SH; Jeong EJ; Noh JY; Kim WJ
    J Infect Chemother; 2016 Aug; 22(8):515-20. PubMed ID: 27234358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal structure and 21-year evolution of Streptococcus pneumoniae serotype 1 isolates in northern Spain.
    Marimon JM; Ercibengoa M; Alonso M; Zubizarreta M; Pérez-Trallero E
    Clin Microbiol Infect; 2009 Sep; 15(9):875-7. PubMed ID: 19702591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.